We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blocking Cell Movement Explored to Stop the Spread of Cancer

By LabMedica International staff writers
Posted on 14 Jul 2014
Learning more about how cells travel through the body could lead to innovative new treatments to block cancer cells from metastasizing and causing secondary tumors, according to new research.

Scientists discovered that cells can change into an invasive, liquid-like state to readily move through the thin channels in the human body. More...
This transformation is activated by chemical signals, which could be blocked to stop cancer cells from spreading. Most cancer deaths are not caused by to primary tumors, but to secondary tumors in major organs, such as the lungs or brain, caused by cells moving from the original tumor to other places in the body.

The study led by the University College London (UCL; UK) researchers and published July 8, 2014, in the Journal of Cell Biology, used embryonic cells to better determine how groups of cells move in a developmental process similar to that exploited by cancer to spread around the body. The scientists reported that a molecule called lysophosphatidic acid (LPA) transforms cells from a solid-like to a liquid-like state, allowing cells to flow between normal tissues in the body. They were able to turn off the signals from LPA, stopping the cells from moving down the narrow, blood vessel-like channels.

Lead scientist Prof. Roberto Mayor, from the UCL department of cell and developmental biology, said, “We have found a way to stop the movement of embryonic cells by blocking LPA signals. It is likely that a similar mechanism operates during cancer invasion, which suggests a possible alternative which cancer treatments might work in the future, if therapies can be targeted to limit the tissue fluidity of tumors. Our findings are important for the fields of cell, developmental and cancer biology. Previously, we thought cells only moved around the body either individually or as groups of well-connected cells. What we have discovered is a hybrid state where cells loosen their links to neighboring cells but still move en masse together, like a liquid. Moreover, we can stop this movement.”

Related Links:

University College London



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Collection and Transport System
PurSafe Plus®
Hemodynamic System Monitor
OptoMonitor
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers have developed two rapid blood tests for early Alzheimer’s detection (Photo courtesy of UConn)

Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages

Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.